Cargando…
Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment
Moyamoya disease (MMD) is a chronic cerebrovascular disease characterized by progressive stenosis of the arteries of the circle of Willis, with the formation of collateral vascular network at the base of the brain. Its clinical manifestations are complicated. Numerous studies have attempted to clari...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413783/ https://www.ncbi.nlm.nih.gov/pubmed/34279201 http://dx.doi.org/10.2174/1570159X19666210716114016 |
_version_ | 1784775834829062144 |
---|---|
author | Zhang, Xin Xiao, Weiping Zhang, Qing Xia, Ding Gao, Peng Su, Jiabin Yang, Heng Gao, Xinjie Ni, Wei Lei, Yu Gu, Yuxiang |
author_facet | Zhang, Xin Xiao, Weiping Zhang, Qing Xia, Ding Gao, Peng Su, Jiabin Yang, Heng Gao, Xinjie Ni, Wei Lei, Yu Gu, Yuxiang |
author_sort | Zhang, Xin |
collection | PubMed |
description | Moyamoya disease (MMD) is a chronic cerebrovascular disease characterized by progressive stenosis of the arteries of the circle of Willis, with the formation of collateral vascular network at the base of the brain. Its clinical manifestations are complicated. Numerous studies have attempted to clarify the clinical features of MMD, including its epidemiology, genetic characteristics, and pathophysiology. With the development of neuroimaging techniques, various neuroimaging modalities with different advantages have deepened the understanding of MMD in terms of structural, functional, spatial, and temporal dimensions. At present, the main treatment for MMD focuses on neurological protection, cerebral blood flow reconstruction, and neurological rehabilitation, such as pharmacological treatment, surgical revascularization, and cognitive rehabilitation. In this review, we discuss recent progress in understanding the clinical features, in the neuroimaging evaluation and treatment of MMD. |
format | Online Article Text |
id | pubmed-9413783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-94137832022-10-04 Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment Zhang, Xin Xiao, Weiping Zhang, Qing Xia, Ding Gao, Peng Su, Jiabin Yang, Heng Gao, Xinjie Ni, Wei Lei, Yu Gu, Yuxiang Curr Neuropharmacol Neurology Moyamoya disease (MMD) is a chronic cerebrovascular disease characterized by progressive stenosis of the arteries of the circle of Willis, with the formation of collateral vascular network at the base of the brain. Its clinical manifestations are complicated. Numerous studies have attempted to clarify the clinical features of MMD, including its epidemiology, genetic characteristics, and pathophysiology. With the development of neuroimaging techniques, various neuroimaging modalities with different advantages have deepened the understanding of MMD in terms of structural, functional, spatial, and temporal dimensions. At present, the main treatment for MMD focuses on neurological protection, cerebral blood flow reconstruction, and neurological rehabilitation, such as pharmacological treatment, surgical revascularization, and cognitive rehabilitation. In this review, we discuss recent progress in understanding the clinical features, in the neuroimaging evaluation and treatment of MMD. Bentham Science Publishers 2022-02-17 2022-02-17 /pmc/articles/PMC9413783/ /pubmed/34279201 http://dx.doi.org/10.2174/1570159X19666210716114016 Text en © 2022 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Neurology Zhang, Xin Xiao, Weiping Zhang, Qing Xia, Ding Gao, Peng Su, Jiabin Yang, Heng Gao, Xinjie Ni, Wei Lei, Yu Gu, Yuxiang Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment |
title | Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment |
title_full | Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment |
title_fullStr | Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment |
title_full_unstemmed | Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment |
title_short | Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment |
title_sort | progression in moyamoya disease: clinical features, neuroimaging evaluation, and treatment |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413783/ https://www.ncbi.nlm.nih.gov/pubmed/34279201 http://dx.doi.org/10.2174/1570159X19666210716114016 |
work_keys_str_mv | AT zhangxin progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment AT xiaoweiping progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment AT zhangqing progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment AT xiading progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment AT gaopeng progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment AT sujiabin progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment AT yangheng progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment AT gaoxinjie progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment AT niwei progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment AT leiyu progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment AT guyuxiang progressioninmoyamoyadiseaseclinicalfeaturesneuroimagingevaluationandtreatment |